Page last updated: 2024-10-31

nafamostat and Gram-Negative Bacterial Infections

nafamostat has been researched along with Gram-Negative Bacterial Infections in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Gram-Negative Bacterial Infections: Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheadle, WG1
Hanasawa, K1
Gallinaro, RN1
Nimmanwudipong, T1
Kodama, M1
Polk, HC1

Other Studies

1 other study available for nafamostat and Gram-Negative Bacterial Infections

ArticleYear
Endotoxin filtration and immune stimulation improve survival from gram-negative sepsis.
    Surgery, 1991, Volume: 110, Issue:4

    Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antithrombins; Benzamidines; End

1991
chemdatabank.com